Reducing targeting noise by supplementing claims with oncology labs
Accurately targeting chronic liver disease patients for specialty therapy
Accurately reaching patients with rare hematologic disease
Accelerating early RWE exploration without increasing analytic burden
Uncover what keeps GLP-1 patients on therapy, and what doesn’t
Demonstrating the safety and effectiveness of an anti-seizure medication with real-world data
Validating audience quality to improve campaign outcomes
Media attribution for real-time campaign optimization
